EndoflipTM 300 System— 510(k) K231861

Substantially Equivalent

Covidien, LLC

FDA 510(k) clearance K231861 for EndoflipTM 300 System, Substantially Equivalent on 2023-07-21. Applicant: Covidien, LLC. Device class: 2.

Clearance details

Applicant
Covidien, LLC
Product code
Code FFX
Device class
Class 2
Regulation
21 CFR 876.1725
Advisory panel
Gastroenterology, Urology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Special
Location
Santa Clara, CA, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code FFX

view all

More clearances from Covidien, LLC

view all

Adverse events under product code FFX

product code FFX
Other
1
Total
1

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.